Which has grown faster, ABCL or VCYT?

Over the past five years, VCYT grew revenue faster — ABCL at a -31.78% CAGR versus VCYT at 28.98%.

Is ABCL or VCYT more profitable?

VCYT runs the higher net margin — ABCL at -248.83% versus VCYT at 20.37%.

How have ABCL and VCYT total returns compared?

Over the past 5 years, ABCL delivered -3.57% and VCYT delivered 1.45% annualized total return. Past performance doesn't predict future results.

AbCellera Biologics Inc. (ABCL) vs Veracyte, Inc. (VCYT)

A side-by-side comparison of AbCellera Biologics Inc. and Veracyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ABCL

AbCellera Biologics Inc.

$4.02B

$13.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VCYT

Veracyte, Inc.

$3.56B

$44.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ABCL vs VCYT

growth of $100 · dividends reinvested · last 6y

ABCL -76.6% (-21.5%/yr)VCYT -14.2% (-2.5%/yr)VCYT compounded faster over this window

ABCL VCYT

ABCL vs VCYT: by the numbers

•ABCL is the larger company ($4.02B vs $3.56B market cap).
•VCYT is profitable (20.37% net margin) while ABCL runs a net loss (-248.83%).
•VCYT grew revenue faster over the past five years (28.98% vs -31.78% CAGR).

Metrics side by side

Valuation

Metric	ABCL	VCYT
P/E ratio	N/A	31.89
Forward P/E	N/A	23.33
P/S ratio	60.68	6.34
P/B ratio	4.48	2.57
EV / EBITDA	N/A	28.34
FCF yield	N/A	4.64%

Profitability

Metric	ABCL	VCYT
Gross margin	61.64%	72.09%
Operating margin	-288.98%	17.03%
Net margin	-248.83%	20.37%
ROE	-18.38%	8.25%
ROIC	-17.95%	6.72%

Growth (annualized)

Metric	ABCL	VCYT
Revenue CAGR (5Y)	-31.78%	28.98%
Total return CAGR (5Y)	-3.57%	1.45%

Frequently asked

Which has grown faster, ABCL or VCYT?: Over the past five years, VCYT grew revenue faster — ABCL at a -31.78% CAGR versus VCYT at 28.98%.
Is ABCL or VCYT more profitable?: VCYT runs the higher net margin — ABCL at -248.83% versus VCYT at 20.37%.
How have ABCL and VCYT total returns compared?: Over the past 5 years, ABCL delivered -3.57% and VCYT delivered 1.45% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABCL analysis Full VCYT analysis Interactive comparison tool

Dig into the metrics

Veracyte P/E ratio AbCellera Biologics ROE Veracyte ROE AbCellera Biologics operating margin Veracyte operating margin AbCellera Biologics revenue growth Veracyte revenue growth AbCellera Biologics free cash flow Veracyte free cash flow

AbCellera Biologics & Veracyte appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.